pioglitazone HCl

DRUG4 trials

Sponsors

Daiichi Sankyo, Daiichi Sankyo Co., Ltd., InteKrin Therapeutics, Inc., Janssen Research & Development, LLC

Conditions

Healthy VolunteersType 2 DiabetesType 2 Diabetes Mellitus

Phase 1

A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants

CompletedNCT01873001

Janssen Research & Development, LLCHealthy Volunteers

Start: 2013-05-31End: 2013-07-31Updated: 2014-04-17

Phase 2

Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes

CompletedNCT00575874

Daiichi Sankyo Co., Ltd.Type 2 Diabetes

Start: 2007-08-31End: 2009-01-31Target: 150Updated: 2009-02-09

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

CompletedNCT00631007

InteKrin Therapeutics, Inc.Type 2 Diabetes Mellitus

Start: 2008-02-29End: 2009-09-30Updated: 2010-09-13

Phase 3

Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus

TerminatedNCT00571519

Daiichi SankyoType 2 Diabetes Mellitus

Start: 2007-11-14End: 2008-05-23Updated: 2021-05-26